CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma
- 346 Downloads
Chromodomain helicase/ATPase DNA binding protein 1-like (CHD1L) gene is a newly identified oncogene located at Chr1q21 and it is amplified in many solid tumors. In this study, we intended to investigate the clinical significance of CHD1L expression in human glioma and its biological function in glioma cells. Western blot and immunohistochemistry analysis showed that CHD1L was overexpressed in glioma tissues and glioma cell lines. In addition, the expression level of CHD1L was positively correlated with glioma pathological grade and Ki-67 expression. Kaplan–Meier curve indicated that high expression of CHD1L may result in poor prognosis of glioma patients. Accordingly, suppression of CHD1L in glioma cells was shown to induce cell cycle arrest and increase apoptosis. In addition, knockdown of CHD1L significantly accelerated migration and invasion ability of glioma cells. Together our findings suggest that CHD1L is involved in the progression of glioma and may be a novel target for further therapy.
KeywordsCHD1L Glioma Cell cycle Apoptosis Migration
This work was supported by the National Natural Science Foundation of China (Nos. 81201858, 81272789), the National Natural Science Foundation of Jiangsu province (No. BK2012231), and the Nantong Society Undertaking and Technological Innovation (HS2014069).
Compliance with Ethical Standards
Conflict of interest
- Chen L, Hu L, Chan TH, Tsao GS, Xie D, Huo KK, Fu L, Ma S, Zheng BJ, Guan XY (2009a) Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 50(1):122–129. doi: 10.1002/hep.22933 CrossRefPubMedGoogle Scholar
- Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S, Wang J, Dong SS, Tang KH, Xie D, Li Y, Guan XY (2010) CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Investig 120(4):1178–1191. doi: 10.1172/JCI40665 CrossRefPubMedPubMedCentralGoogle Scholar
- Ma NF, Hu L, Fung JM, Xie D, Zheng BJ, Chen L, Tang DJ, Fu L, Wu Z, Chen M, Fang Y, Guan XY (2008) Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology 47(2):503–510. doi: 10.1002/hep.22072 CrossRefPubMedGoogle Scholar
- Venkataramanaa NK, Venkatesh PK, Dwarakanath BS, Vani S (2013) Protective effect on normal brain tissue during a combinational therapy of 2-deoxy-d-glucose and hypofractionated irradiation in malignant gliomas. Asian J Neurosurg 8(1):9–14. doi: 10.4103/1793-5482.110274 CrossRefPubMedPubMedCentralGoogle Scholar
- Yamashita Y, Kasugai I, Sato M, Tanuma N, Sato I, Nomura M, Yamashita K, Sonoda Y, Kumabe T, Tominaga T, Katakura R, Shima H (2010) CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples. J Neurooncol 100(1):43–49. doi: 10.1007/s11060-010-0147-3 CrossRefPubMedGoogle Scholar
- Zolota V, Sirinian C, Melachrinou M, Symeonidis A, Bonikos DS (2007) Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients’ survival. Pathol Res Pract 203(4):199–207. doi: 10.1016/j.prp.2007.01.010 CrossRefPubMedGoogle Scholar